Tiziana Life Sciences (TLSA) Enterprise Value (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Enterprise Value of -$4.0 million for Q4 2025, down 7.68% year-over-year from -$4.3 million in Q4 2024, and up 44.7% quarter-over-quarter from -$7.3 million in Q2 2025.
Tiziana Life Sciences (TLSA) Enterprise Value (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Enterprise Value history runs 9 years deep, the most recent figure standing at -$4.0 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 7.68% year-over-year to -$4.0 million; the TTM figure through Dec 2025 stood at -$4.0 million (down 7.68% YoY), while the FY2025 annual figure was -$4.0 million, down 7.68% from the prior year.
- Enterprise Value for Q4 2025 stood at -$4.0 million, up from -$7.3 million in the prior quarter.
- The five-year high for Enterprise Value was $455000.0 in Q2 2024, with the low at -$54.0 million in Q2 2021.
- The 5-year median for Enterprise Value is -$7.0 million (2023), against an average of -$16.4 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 106.81% in 2024, then tumbled 1693.63% in 2025.
- Tiziana Life Sciences' Enterprise Value stood at -$42.2 million in 2021, then surged by 54.98% to -$19.0 million in 2022, then jumped by 95.89% to -$781000.0 in 2023, then sank by 376.82% to -$3.7 million in 2024, then slipped by 7.68% to -$4.0 million in 2025.
- Business Quant data shows TLSA's Enterprise Value at -$4.0 million in Q4 2025, -$7.3 million in Q2 2025, and -$3.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 2.12 Bn |
| 10 | Tiziana Life Sciences | 133.07 Mn | 129.06 Mn | - | -4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.01 Mn |
| Jun 30, 2025 | -7.25 Mn |
| Dec 31, 2024 | -3.72 Mn |
| Jun 30, 2024 | 455,000.00 |
| Dec 31, 2023 | -781,000.00 |
| Jun 30, 2023 | -6.68 Mn |
| Dec 31, 2022 | -18.99 Mn |
| Jun 30, 2022 | -26.54 Mn |
| Dec 31, 2021 | -42.19 Mn |
| Jun 30, 2021 | -53.96 Mn |
| Dec 31, 2020 | -63.67 Mn |
| Jun 30, 2020 | -8.94 Mn |
| Dec 31, 2019 | -196,715.91 |
| Jun 30, 2019 | -572,409.12 |
| Dec 31, 2018 | -5.36 Mn |
| Jun 30, 2018 | -89,915.42 |
| Dec 31, 2017 | -63,727.91 |